Pancreatic Cancer Research

ResearcherChiba UniversityActive in the last 2 years

Ryotaro Eto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5245-3149; OpenAlex author ID A5047235766. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 4

  1. Tumor-associated tissue-resident macrophages drive pancreatic cancer progression through IGF1-IGF1R signaling Co-author DOI 10.64898/2026.05.08.723679↗
  2. A pancreatic cancer organoid incorporating macrophages reveals the correlation between the diversity of tumor-associated macrophages and cancer cell survival. Co-author DOI 10.1016/j.biomaterials.2024.122838↗
  3. Inhibition of C5a-C5aR1 axis suppresses tumour progression by enhancing antitumour immunity and chemotherapeutic effect in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41416-025-03185-0↗
  4. Semaphorin 3 C enhances putative cancer stemness and accelerates peritoneal dissemination in pancreatic cancer. Co-author DOI 10.1186/s12935-023-03008-3↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masayuki Ohtsuka · 4 shared papers, 2023–2026 · strength 0.96
  2. Shigetsugu Takano · 2 shared papers, 2023–2025 · strength 0.49
  3. Yohei Miyagi · 2 shared papers, 2025–2026 · strength 0.47
  4. Takanori Konishi · 2 shared papers, 2025–2026 · strength 0.47
  5. Shunsuke Tabe · 2 shared papers, 2025–2026 · strength 0.47
  6. Hideki Taniguchi · 2 shared papers, 2025–2026 · strength 0.47
  7. Yuya Yamamoto · 2 shared papers, 2025–2026 · strength 0.47
  8. Kenta Takeuchi · 2 shared papers, 2025–2026 · strength 0.47
  9. Kensuke Suzuki · 1 shared paper, 2025 · strength 0.27
  10. Satoshi Tomizawa · 1 shared paper, 2023 · strength 0.22
  11. Soichiro Morinaga · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.